Effectiveness of Pashanabhedadi Ghana vati in comparison with Svadamstradi Ghana Vati in the management of kideny stone

A comparative study to evaluate the antinephrolithiatic activity of Pashanabhedadi Ghana Vati and Svadamstradi Ghana Vati in the management of Mutrashmari (nephrolithiasis): A randomized controlled trial. - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/02/081154

Enrollment

Registered

2025-02-24

Start date

Unknown

Completion date

Unknown

Last updated

2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N200- Calculus of kidney

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age: 21-60 years 2. Kidney stone size up to 10 mm as measured on USG 3. Radiographic USG evidence of the renal stone.

Exclusion criteria

Exclusion criteria: 1. Patients not willing for trial and follow up 2. Chronic Renal failure. 3. Acute abdominal pain. 4. Cases that require surgical intervention. 5. Gross Hematuria grater 50rbcHPF 6 Ashmari due to Gudagata vata 7 Kidney stone and Bladder Stone size more than 10 mm 8 Patients having Ureteric stone 9 Known cases of Malignancy and tuberculosis 10 Patients with HbA1C grater or equal 9 And Grade 3 hypertension SBP greater than or equal to 180mmHg and or DBP greater than or equal to 110mmHg 11 Known cases of HIV Human Immunodeficiency Virus VDRL Venereal Disease Research Laboratory and Hepatitis B positive

Design outcomes

Primary

Measure	Time frame
•To evaluate the effectiveness of Pashanabhedadi Ghana Vati relief of signs & symptoms of Mutrashmari (Nephrolithiasis) and expulsion of formed stones. Timepoint: •The patient will be assessed on 1st 2nd 3rd and 4th week •Follow up at 1 month to see the sustainability of the intervention	—

Secondary

Measure	Time frame
• To evaluate the efficacy of Pashanabhedadi Ghana Vati in reducing the size of Mutrashmari in selected patients. • To assess the associated factors related to renal stone in selected patients. • To generate the data of chemical composition of the expelled stone . Timepoint: • The patient will be assessed on baseline 2nd 3rd & 4th week • Follow up at 1 month to see the sustainability of the intervention	—

Measure

Time frame

• To evaluate the efficacy of Pashanabhedadi Ghana Vati in reducing the size of Mutrashmari in selected patients. • To assess the associated factors related to renal stone in selected patients. • To generate the data of chemical composition of the expelled stone . Timepoint: • The patient will be assessed on baseline 2nd 3rd & 4th week • Follow up at 1 month to see the sustainability of the intervention

—

Countries

India

Contacts

Public ContactVaishnavi Chauhan

All India Institute of Ayurveda

drvyasayu@gmail.com7838957972

Outcome results